RAMELLA, SARA
 Distribuzione geografica
Continente #
AS - Asia 9.030
EU - Europa 939
NA - Nord America 887
AF - Africa 16
OC - Oceania 14
SA - Sud America 10
Totale 10.896
Nazione #
SG - Singapore 8.106
US - Stati Uniti d'America 854
HK - Hong Kong 442
CN - Cina 381
IT - Italia 358
GB - Regno Unito 179
DE - Germania 140
NL - Olanda 72
EE - Estonia 57
FI - Finlandia 46
IN - India 42
CA - Canada 29
TR - Turchia 17
UA - Ucraina 16
CZ - Repubblica Ceca 14
ZA - Sudafrica 13
AU - Australia 12
ID - Indonesia 11
FR - Francia 9
SE - Svezia 9
RO - Romania 8
AT - Austria 7
BR - Brasile 7
BD - Bangladesh 6
JP - Giappone 6
ES - Italia 5
TW - Taiwan 4
MX - Messico 3
TH - Thailandia 3
BE - Belgio 2
CH - Svizzera 2
IR - Iran 2
NZ - Nuova Zelanda 2
PE - Perù 2
PL - Polonia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
IQ - Iraq 1
JM - Giamaica 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
VN - Vietnam 1
Totale 10.896
Città #
Singapore 382
Hong Kong 376
Ashburn 238
Hefei 200
Boardman 195
London 166
Shanghai 137
Rome 131
Munich 83
Los Angeles 42
Amsterdam 38
San Francisco 32
Council Bluffs 28
Turku 27
Pune 26
Seattle 24
Washington 23
Milan 21
Helsinki 19
Toronto 18
Naples 17
Brno 12
Sona 11
Chicago 10
West Jordan 10
Boston 8
Santa Clara 8
Nuremberg 7
Hanover 6
New York 6
Redmond 6
Ankara 5
Atlanta 5
Bologna 5
Melbourne 5
Palermo 5
Phoenix 5
Rocca di Papa 5
Stockholm 5
São Paulo 5
Beijing 4
Buffalo 4
Cascina 4
Charlotte 4
Dallas 4
Florence 4
Frankfurt am Main 4
Haikou 4
Tokyo 4
Umeå 4
Vicenza 4
Andover 3
Aprilia 3
Bangkok 3
Brooklyn 3
Canberra 3
Central 3
Chennai 3
Denver 3
Guangzhou 3
Handan 3
Lucca 3
Markham 3
Mexico City 3
Montreal 3
Sydney 3
Turin 3
Vaddangi 3
Vienna 3
Azzano San Paolo 2
Bangalore 2
Banqiao 2
Bari 2
Birmingham 2
Bratislava 2
Bucharest 2
Cleveland 2
Clifton 2
Cologno Monzese 2
Dhaka 2
East Orange 2
Genoa 2
Hangzhou 2
Harbin 2
Jakarta 2
Johannesburg 2
Lima 2
Marseille 2
Olomouc 2
Osimo 2
Pescara 2
Sant'Anastasia 2
Shenzhen 2
Southall 2
Taipei 2
Tallinn 2
Temecula 2
Warsaw 2
Wernigerode 2
Xi'an 2
Totale 2.512
Nome #
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 227
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 224
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 219
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 198
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 197
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 193
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 190
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 189
Exploring Deep Pathomics in Lung Cancer 188
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 187
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 185
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 183
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 183
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 182
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 181
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 181
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 178
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 178
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 177
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 177
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 175
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 175
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 174
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 173
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 172
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 166
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 166
Preventing Cardiotoxicity in Personalized Breast Irradiation 163
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 162
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 162
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 138
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 119
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 115
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 102
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 100
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 98
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 95
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 94
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 94
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 90
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 89
MR imaging of rectal cancer before and after chemoradiation therapy 89
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 88
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 88
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 88
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 87
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 87
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 86
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 86
A deep learning approach for overall survival prediction in lung cancer with missing values 84
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 84
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 83
Evaluating GANs in Medical Imaging 83
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 82
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 82
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 82
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 81
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 80
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 80
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 79
Chemoradiation for stage III non-small cell lung cancer 77
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 77
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 77
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 74
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 74
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 67
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 64
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 62
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 62
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 60
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 60
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 60
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 55
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 37
Protective Role of Natural Compounds under Radiation-Induced Injury 30
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 27
Radiation therapy of breast cancer. Reasoned approach to a clinical case 26
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 25
Radioprotezione 25
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 25
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. 22
Radiation Therapy in management of malignant pleural mesothelioma: Pros (2). 22
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 22
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 21
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. 21
Neoadjuvant concurrent chemotherapy and radiotherapy in non-small cell lung cancer 20
Lung Cancer in Italy. 20
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine 20
Dose fractionation and biological optimization in lung cancer 19
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 19
Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification 19
Preliminary results of a phase II study of induction Folfirinox followed by chemoradiation in LAPC 19
Ruolo della Radioterapia. In: “Percorso Terapeutico nel Carcinoma Polmonare (NSCLC)” 19
Evidence-Based Radiotherapy: “Hot Topics” 2010 NSCLC 19
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 19
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement 19
Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines 19
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 18
Proton beam or photon beam radiotherapy in the treatment of non-small-cell lung cancer 18
Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey. 18
Totale 9.695
Categoria #
all - tutte 63.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 6 6 5 1 3 6 6 13 7 0 168
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024592 21 62 36 35 60 251 14 36 4 22 11 40
2024/20259.995 96 48 221 64 113 219 153 34 522 725 3.591 4.209
2025/202623 23 0 0 0 0 0 0 0 0 0 0 0
Totale 11.003